Litigation Details for Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2022)
✉ Email this page to a colleague
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-11-21 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | 2024-06-25 |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Parties | AARON S. KESSELHEIM | ||
| Patents | 10,278,935; 10,383,840; 10,568,861; 7,022,713; 7,511,131; 8,293,727; 8,293,728; 8,298,554; 8,314,086; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,410,086; 8,431,560; 8,440,650; 8,455,472; 8,518,929; 8,524,698; 8,546,372; 8,551,521; 8,563,608; 8,617,593; 8,617,594; 8,623,406; 8,642,077; 8,669,245; 8,680,144; 8,691,871; 8,703,185; 8,709,475; 9,603,826; 9,610,272; 9,623,001; 9,693,984; 9,693,985; 9,693,986; 9,700,537; 9,918,954 | ||
| Attorneys | Eimeric Reig-Plessis, Attorney | ||
| Firms | Perkins Coie, LLP, Firm: 202-654-6200 | ||
| Link to Docket | External link to docket | ||
Details for Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-03-21 | 15 | 005,852, filed on Jun. 12, 2018, now Pat. No. 10,278,935, which is a continuation of application …present filed Jun. 12, 2018 (now U.S. Pat. No. 10,278,935), which …asserted patents the ’537 and ’861 patents USPTO United States Patent and Trademark…relationship between the non-patented use and patented use is reversed: the non- patented use here (i.e., the …the broader, off-patent use induced the specific, patented use because the off-patented treatment of severe | External link to document | |
| 2024-08-22 | 47 | listed U.S. Patent 9,700,537 (“the ’537 patent”) and U.S. Patent 10,568,861 (“the ’861 patent”) (collectively…the ’537 patent, and at least claims 1 and 2 of the ’861 patent. Claim 1 of the ’537 patent recites:…]hen the brand’s patent on the drug compound has expired and the brand holds patents on only some approved…asserted U.S. Patent 8,642,077 against Hikma, but the parties’ dispute as to that patent has been resolved…dium. ’537 patent, col. 15, l. 64–col. 16, l. 22. Claims 1 and 2 of the ’861 patent recite: | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
